Global Teriflunomide Market Growth (Status and Outlook) 2023-2029

February 2023 | 89 pages | ID: GF4100C33DDFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.

LPI (LP Information)' newest research report, the “Teriflunomide Industry Forecast” looks at past sales and reviews total world Teriflunomide sales in 2022, providing a comprehensive analysis by region and market sector of projected Teriflunomide sales for 2023 through 2029. With Teriflunomide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Teriflunomide industry.

This Insight Report provides a comprehensive analysis of the global Teriflunomide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Teriflunomide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Teriflunomide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Teriflunomide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Teriflunomide.

The global Teriflunomide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Teriflunomide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Teriflunomide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Teriflunomide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Teriflunomide players cover Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Teriflunomide market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Tablets
• Powder

Segmentation by application

• Immunosuppression
• Cancer Treatment

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sanofi Aventis
• Genzyme Corporation
• Amneal Pharmaceuticals NY LC
• Glenmark Pharmaceuticals
• Msn Laboratories Private Limited

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Teriflunomide Market Size 2018-2029
  2.1.2 Teriflunomide Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Teriflunomide Segment by Type
  2.2.1 Tablets
  2.2.2 Powder
2.3 Teriflunomide Market Size by Type
  2.3.1 Teriflunomide Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Teriflunomide Market Size Market Share by Type (2018-2023)
2.4 Teriflunomide Segment by Application
  2.4.1 Immunosuppression
  2.4.2 Cancer Treatment
2.5 Teriflunomide Market Size by Application
  2.5.1 Teriflunomide Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Teriflunomide Market Size Market Share by Application (2018-2023)

3 TERIFLUNOMIDE MARKET SIZE BY PLAYER

3.1 Teriflunomide Market Size Market Share by Players
  3.1.1 Global Teriflunomide Revenue by Players (2018-2023)
  3.1.2 Global Teriflunomide Revenue Market Share by Players (2018-2023)
3.2 Global Teriflunomide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TERIFLUNOMIDE BY REGIONS

4.1 Teriflunomide Market Size by Regions (2018-2023)
4.2 Americas Teriflunomide Market Size Growth (2018-2023)
4.3 APAC Teriflunomide Market Size Growth (2018-2023)
4.4 Europe Teriflunomide Market Size Growth (2018-2023)
4.5 Middle East & Africa Teriflunomide Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Teriflunomide Market Size by Country (2018-2023)
5.2 Americas Teriflunomide Market Size by Type (2018-2023)
5.3 Americas Teriflunomide Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Teriflunomide Market Size by Region (2018-2023)
6.2 APAC Teriflunomide Market Size by Type (2018-2023)
6.3 APAC Teriflunomide Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Teriflunomide by Country (2018-2023)
7.2 Europe Teriflunomide Market Size by Type (2018-2023)
7.3 Europe Teriflunomide Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Teriflunomide by Region (2018-2023)
8.2 Middle East & Africa Teriflunomide Market Size by Type (2018-2023)
8.3 Middle East & Africa Teriflunomide Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TERIFLUNOMIDE MARKET FORECAST

10.1 Global Teriflunomide Forecast by Regions (2024-2029)
  10.1.1 Global Teriflunomide Forecast by Regions (2024-2029)
  10.1.2 Americas Teriflunomide Forecast
  10.1.3 APAC Teriflunomide Forecast
  10.1.4 Europe Teriflunomide Forecast
  10.1.5 Middle East & Africa Teriflunomide Forecast
10.2 Americas Teriflunomide Forecast by Country (2024-2029)
  10.2.1 United States Teriflunomide Market Forecast
  10.2.2 Canada Teriflunomide Market Forecast
  10.2.3 Mexico Teriflunomide Market Forecast
  10.2.4 Brazil Teriflunomide Market Forecast
10.3 APAC Teriflunomide Forecast by Region (2024-2029)
  10.3.1 China Teriflunomide Market Forecast
  10.3.2 Japan Teriflunomide Market Forecast
  10.3.3 Korea Teriflunomide Market Forecast
  10.3.4 Southeast Asia Teriflunomide Market Forecast
  10.3.5 India Teriflunomide Market Forecast
  10.3.6 Australia Teriflunomide Market Forecast
10.4 Europe Teriflunomide Forecast by Country (2024-2029)
  10.4.1 Germany Teriflunomide Market Forecast
  10.4.2 France Teriflunomide Market Forecast
  10.4.3 UK Teriflunomide Market Forecast
  10.4.4 Italy Teriflunomide Market Forecast
  10.4.5 Russia Teriflunomide Market Forecast
10.5 Middle East & Africa Teriflunomide Forecast by Region (2024-2029)
  10.5.1 Egypt Teriflunomide Market Forecast
  10.5.2 South Africa Teriflunomide Market Forecast
  10.5.3 Israel Teriflunomide Market Forecast
  10.5.4 Turkey Teriflunomide Market Forecast
  10.5.5 GCC Countries Teriflunomide Market Forecast
10.6 Global Teriflunomide Forecast by Type (2024-2029)
10.7 Global Teriflunomide Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Sanofi Aventis
  11.1.1 Sanofi Aventis Company Information
  11.1.2 Sanofi Aventis Teriflunomide Product Offered
  11.1.3 Sanofi Aventis Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Sanofi Aventis Main Business Overview
  11.1.5 Sanofi Aventis Latest Developments
11.2 Genzyme Corporation
  11.2.1 Genzyme Corporation Company Information
  11.2.2 Genzyme Corporation Teriflunomide Product Offered
  11.2.3 Genzyme Corporation Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Genzyme Corporation Main Business Overview
  11.2.5 Genzyme Corporation Latest Developments
11.3 Amneal Pharmaceuticals NY LC
  11.3.1 Amneal Pharmaceuticals NY LC Company Information
  11.3.2 Amneal Pharmaceuticals NY LC Teriflunomide Product Offered
  11.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Amneal Pharmaceuticals NY LC Main Business Overview
  11.3.5 Amneal Pharmaceuticals NY LC Latest Developments
11.4 Glenmark Pharmaceuticals
  11.4.1 Glenmark Pharmaceuticals Company Information
  11.4.2 Glenmark Pharmaceuticals Teriflunomide Product Offered
  11.4.3 Glenmark Pharmaceuticals Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Glenmark Pharmaceuticals Main Business Overview
  11.4.5 Glenmark Pharmaceuticals Latest Developments
11.5 Msn Laboratories Private Limited
  11.5.1 Msn Laboratories Private Limited Company Information
  11.5.2 Msn Laboratories Private Limited Teriflunomide Product Offered
  11.5.3 Msn Laboratories Private Limited Teriflunomide Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Msn Laboratories Private Limited Main Business Overview
  11.5.5 Msn Laboratories Private Limited Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Teriflunomide Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Powder
Table 4. Teriflunomide Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Teriflunomide Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Teriflunomide Market Size Market Share by Type (2018-2023)
Table 7. Teriflunomide Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Teriflunomide Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Teriflunomide Market Size Market Share by Application (2018-2023)
Table 10. Global Teriflunomide Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Teriflunomide Revenue Market Share by Player (2018-2023)
Table 12. Teriflunomide Key Players Head office and Products Offered
Table 13. Teriflunomide Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Teriflunomide Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Teriflunomide Market Size Market Share by Regions (2018-2023)
Table 18. Global Teriflunomide Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Teriflunomide Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Teriflunomide Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Teriflunomide Market Size Market Share by Country (2018-2023)
Table 22. Americas Teriflunomide Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Teriflunomide Market Size Market Share by Type (2018-2023)
Table 24. Americas Teriflunomide Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Teriflunomide Market Size Market Share by Application (2018-2023)
Table 26. APAC Teriflunomide Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Teriflunomide Market Size Market Share by Region (2018-2023)
Table 28. APAC Teriflunomide Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Teriflunomide Market Size Market Share by Type (2018-2023)
Table 30. APAC Teriflunomide Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Teriflunomide Market Size Market Share by Application (2018-2023)
Table 32. Europe Teriflunomide Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Teriflunomide Market Size Market Share by Country (2018-2023)
Table 34. Europe Teriflunomide Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Teriflunomide Market Size Market Share by Type (2018-2023)
Table 36. Europe Teriflunomide Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Teriflunomide Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Teriflunomide Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Teriflunomide Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Teriflunomide Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Teriflunomide Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Teriflunomide Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Teriflunomide Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Teriflunomide
Table 45. Key Market Challenges & Risks of Teriflunomide
Table 46. Key Industry Trends of Teriflunomide
Table 47. Global Teriflunomide Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Teriflunomide Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Teriflunomide Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Teriflunomide Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Sanofi Aventis Details, Company Type, Teriflunomide Area Served and Its Competitors
Table 52. Sanofi Aventis Teriflunomide Product Offered
Table 53. Sanofi Aventis Teriflunomide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Sanofi Aventis Main Business
Table 55. Sanofi Aventis Latest Developments
Table 56. Genzyme Corporation Details, Company Type, Teriflunomide Area Served and Its Competitors
Table 57. Genzyme Corporation Teriflunomide Product Offered
Table 58. Genzyme Corporation Main Business
Table 59. Genzyme Corporation Teriflunomide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Genzyme Corporation Latest Developments
Table 61. Amneal Pharmaceuticals NY LC Details, Company Type, Teriflunomide Area Served and Its Competitors
Table 62. Amneal Pharmaceuticals NY LC Teriflunomide Product Offered
Table 63. Amneal Pharmaceuticals NY LC Main Business
Table 64. Amneal Pharmaceuticals NY LC Teriflunomide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Amneal Pharmaceuticals NY LC Latest Developments
Table 66. Glenmark Pharmaceuticals Details, Company Type, Teriflunomide Area Served and Its Competitors
Table 67. Glenmark Pharmaceuticals Teriflunomide Product Offered
Table 68. Glenmark Pharmaceuticals Main Business
Table 69. Glenmark Pharmaceuticals Teriflunomide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Glenmark Pharmaceuticals Latest Developments
Table 71. Msn Laboratories Private Limited Details, Company Type, Teriflunomide Area Served and Its Competitors
Table 72. Msn Laboratories Private Limited Teriflunomide Product Offered
Table 73. Msn Laboratories Private Limited Main Business
Table 74. Msn Laboratories Private Limited Teriflunomide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Msn Laboratories Private Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Teriflunomide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Teriflunomide Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Teriflunomide Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Teriflunomide Sales Market Share by Country/Region (2022)
Figure 8. Teriflunomide Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Teriflunomide Market Size Market Share by Type in 2022
Figure 10. Teriflunomide in Immunosuppression
Figure 11. Global Teriflunomide Market: Immunosuppression (2018-2023) & ($ Millions)
Figure 12. Teriflunomide in Cancer Treatment
Figure 13. Global Teriflunomide Market: Cancer Treatment (2018-2023) & ($ Millions)
Figure 14. Global Teriflunomide Market Size Market Share by Application in 2022
Figure 15. Global Teriflunomide Revenue Market Share by Player in 2022
Figure 16. Global Teriflunomide Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Teriflunomide Market Size 2018-2023 ($ Millions)
Figure 18. APAC Teriflunomide Market Size 2018-2023 ($ Millions)
Figure 19. Europe Teriflunomide Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Teriflunomide Market Size 2018-2023 ($ Millions)
Figure 21. Americas Teriflunomide Value Market Share by Country in 2022
Figure 22. United States Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Teriflunomide Market Size Market Share by Region in 2022
Figure 27. APAC Teriflunomide Market Size Market Share by Type in 2022
Figure 28. APAC Teriflunomide Market Size Market Share by Application in 2022
Figure 29. China Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Teriflunomide Market Size Market Share by Country in 2022
Figure 36. Europe Teriflunomide Market Size Market Share by Type (2018-2023)
Figure 37. Europe Teriflunomide Market Size Market Share by Application (2018-2023)
Figure 38. Germany Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Teriflunomide Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Teriflunomide Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Teriflunomide Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Teriflunomide Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 52. APAC Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 53. Europe Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 55. United States Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 56. Canada Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 59. China Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 60. Japan Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 61. Korea Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 63. India Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 64. Australia Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 65. Germany Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 66. France Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 67. UK Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 68. Italy Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 69. Russia Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 70. Spain Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 73. Israel Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Teriflunomide Market Size 2024-2029 ($ Millions)
Figure 76. Global Teriflunomide Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Teriflunomide Market Size Market Share Forecast by Application (2024-2029)